SC

IQVIA: sourced choices

15 product and go-to-market choices, oldest first. Back to the case study

  1. 2016Product · Combined planning and delivery The merger combined IMS information and technology with Quintiles clinical research. IQ1
  2. 2016Go_To_Market · Merger scope IMS and Quintiles combined established commercial-data and clinical-service customer businesses. IQ1
  3. 2025Product · Site selection IQVIA uses data and analytics to support clinical-trial site identification. IQ2
  4. 2025Product · Recruitment Clinical services include patient recruitment and study operations. IQ2
  5. 2025Product · Longitudinal data The information network includes non-identified longitudinal patient records. IQ2
  6. 2025Product · Standardization IQVIA curates and standardizes healthcare information from multiple sources. IQ2
  7. 2025Product · Linkage Internal tokenization engines connect disparate datasets for longitudinal analysis. IQ2
  8. 2025Product · Study services R&D Solutions provides clinical project management and related delivery work. IQ2
  9. 2025Product · Real-world evidence The company offers analysis of real-world health information beyond conventional trials. IQ2
  10. 2025Go_To_Market · Data sourcing IQVIA licenses information from a broad network of data suppliers. IQ2
  11. 2025Go_To_Market · Contract research Sponsors contract with IQVIA to deliver clinical-research services. IQ2
  12. 2025Go_To_Market · Flexible outsourcing The company supplies both full-service and functional-service arrangements. IQ2
  13. 2025Go_To_Market · Commercial analytics Life-sciences clients buy commercial information and analytical services. IQ2
  14. 2025Go_To_Market · Global delivery Local expertise supports customer programs across international markets. IQ2
  15. 2025Go_To_Market · Technology sales IQVIA sells software and related implementation services to life-sciences clients. IQ2